These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10400888)

  • 41. Effect of recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge with space-providing biomaterials on the augmentation of chronic alveolar ridge defects.
    Barboza EP; Caúla AL; Caúla Fde O; de Souza RO; Geolás Neto L; Sorensen RG; Li XJ; Wikesjö UM
    J Periodontol; 2004 May; 75(5):702-8. PubMed ID: 15212353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthetic alginate is a carrier of OP-1 for bone induction.
    Nanno K; Sugiyasu K; Daimon T; Yoshikawa H; Myoui A
    Clin Orthop Relat Res; 2009 Dec; 467(12):3149-55. PubMed ID: 19475466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2.
    Alam MI; Asahina I; Ohmamiuda K; Takahashi K; Yokota S; Enomoto S
    Biomaterials; 2001 Jun; 22(12):1643-51. PubMed ID: 11374466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Geometry of carriers controlling phenotypic expression in BMP-induced osteogenesis and chondrogenesis.
    Kuboki Y; Jin Q; Takita H
    J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S105-15. PubMed ID: 11314788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiomorphometry and biomechanical assessment of recombinant human bone morphogenetic protein 2 and polymer in rabbit radius ostectomy model.
    Wheeler DL; Chamberland DL; Schmitt JM; Buck DC; Brekke JH; Hollinger JO; Joh SP; Suh KW
    J Biomed Mater Res; 1998; 43(4):365-73. PubMed ID: 9855195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation.
    Liu HW; Chen CH; Tsai CL; Hsiue GH
    Bone; 2006 Oct; 39(4):825-36. PubMed ID: 16782421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of critically sized femoral defects with recombinant BMP-2 delivered by a modified mPEG-PLGA biodegradable thermosensitive hydrogel.
    Peng KT; Hsieh MY; Lin CT; Chen CF; Lee MS; Huang YY; Chang PJ
    BMC Musculoskelet Disord; 2016 Jul; 17():286. PubMed ID: 27421654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiographic analysis of regenerated bone around endosseous implants in the canine using recombinant human bone morphogenetic protein-2.
    Cochran DL; Nummikoski PV; Jones AA; Makins SR; Turek TJ; Buser D
    Int J Oral Maxillofac Implants; 1997; 12(6):739-48. PubMed ID: 9425754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ectopic bone formation after implantation of a slow release system of polylactic acid and rhBMP-2.
    Gruber R; Weich HA; Dullin C; Schliephake H
    Clin Oral Implants Res; 2009 Jan; 20(1):24-30. PubMed ID: 19126104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term evaluation of recombinant human bone morphogenetic protein-2 induced bone formation with a biologic and synthetic delivery system.
    Alpaslan C; Irie K; Takahashi K; Ohashi N; Sakai H; Nakajima T; Ozawa H
    Br J Oral Maxillofac Surg; 1996 Oct; 34(5):414-8. PubMed ID: 8909733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Demineralized bone matrix supplied by bone banks for a carrier of recombinant human bone morphogenetic protein (rhBMP-2): a substitute for autogeneic bone grafts.
    Niederwanger M; Urist MR
    J Oral Implantol; 1996; 22(3-4):210-5. PubMed ID: 9524496
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of combination of recombinant human bone morphogenetic protein-2 and basic fibroblast growth factor or insulin-like growth factor-I on dental implant osseointegration by confocal laser scanning microscopy.
    Lan J; Wang Z; Wang Y; Wang J; Cheng X
    J Periodontol; 2006 Mar; 77(3):357-63. PubMed ID: 16512749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo banking for vascularized autograft bone by intramuscular inoculation of recombinant human bone morphogenetic protein-2 and beta-tricalcium phosphate.
    Chen WJ; Jingushi S; Jingushi K; Iwamoto Y
    J Orthop Sci; 2006 May; 11(3):283-8. PubMed ID: 16721531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations.
    Wikesjö UM; Qahash M; Polimeni G; Susin C; Shanaman RH; Rohrer MD; Wozney JM; Hall J
    J Clin Periodontol; 2008 Nov; 35(11):1001-10. PubMed ID: 18976397
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In Vivo Evaluation of Commercially Available Gel-Type Polyethylene Glycol Membrane for Carrier of Recombinant Human Bone Morphogenetic Protein-2.
    Jang JW; Lee JS; Jung UW; Kim CS; Cho KS
    J Oral Maxillofac Surg; 2017 Feb; 75(2):297.e1-297.e13. PubMed ID: 27288839
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Promotion of the osteogenetic activity of recombinant human bone morphogenetic protein by prostaglandin E1.
    Ono I; Inoue M; Kuboki Y
    Bone; 1996 Dec; 19(6):581-8. PubMed ID: 8968023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The adjunctive effect of a binding peptide on bone morphogenetic protein enhanced bone healing in a rodent model of spinal fusion.
    Alanay A; Chen C; Lee S; Murray SS; Brochmann EJ; Miyazaki M; Napoli A; Wang JC
    Spine (Phila Pa 1976); 2008 Jul; 33(16):1709-13. PubMed ID: 18580546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model.
    Hecht BP; Fischgrund JS; Herkowitz HN; Penman L; Toth JM; Shirkhoda A
    Spine (Phila Pa 1976); 1999 Apr; 24(7):629-36. PubMed ID: 10209790
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid--an experimental study in rats.
    Schliephake H; Weich HA; Dullin C; Gruber R; Frahse S
    Biomaterials; 2008 Jan; 29(1):103-10. PubMed ID: 17936352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects.
    Hong SJ; Kim CS; Han DK; Cho IH; Jung UW; Choi SH; Kim CK; Cho KS
    Biomaterials; 2006 Jul; 27(20):3810-6. PubMed ID: 16574220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.